JPRN-jRCTs032230119招募中1 期
A novel treatment for ulcerative colitis with purastat: A single-center prospective interventional study
Hashimoto Yu0 个研究点目标入组 20 人开始时间: 2023年6月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •1) Ulcerative colitis between the ages of 18 and 85 at the time of enrollment
- •2) Patients with mild to moderate disease on the Partial Mayo score
- •3) Patients who understand the contents of the consent document and give free written consent
排除标准
- •1) Those with concurrent infectious or drug-induced enteritis
- •2) Pregnant or possibly pregnant
- •3) Those who are breast-feeding
- •4) Patients with abnormal blood coagulation function
- •5) Patients with severe organ failure
- •6)History of hypersensitivity to peptide or protein preparations6) Other patients who are deemed unsuitable for registration by the physician in charge.
- •7)Those who are deemed unsuitable for registration by the physician in charge
研究者
相似试验
已完成
不适用
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabulcerative colitisJPRN-UMIN000020402IBD Relapse Prevention Team50
招募中
不适用
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesUlcerative ColitisNL-OMON54471Radboud Universitair Medisch Centrum40
进行中（未招募）
1 期
SB012 for the treatment of active ulcerative colitis: a clinical study in early development (phase IIa), conducted in several study centres, with random assignment of patients to active treatment or placebo, to investigate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once dailyActive ulcerative colitisEUCTR2013-004599-36-DEsterna biologicals GmbH & Co. KG18
进行中（未招募）
1 期
Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO)EUCTR2017-004772-65-DKParaTech A/S120
招募中
不适用
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remissioulcerative colitisJPRN-UMIN000043098Sapporo Medical University150